Selected research
Market Outlook & Growth Opportunities
Global Synthetic Biology Automation Platform Market Outlook and Growth Opportunities 2026
Market perspective
The global Synthetic Biology Automation Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Synthetic Biology Automation Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Synthetic Biology Automation Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Synthetic Biology Automation Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Synthetic Biology Automation Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Synthetic Biology Automation Platform market include Ginkgo Bioworks, Amyris, Codexis, Ningbo Enzyme, Enhe Bio, Strateos, Asimov, Lattice Automation and HighRes Biosolutions, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Synthetic Biology Automation Platform market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Synthetic Biology Automation Platform and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Synthetic Biology Automation Platform revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Synthetic Biology Automation Platform market.
Synthetic Biology Automation Platform Segment by Company
Ginkgo Bioworks
Amyris
Codexis
Ningbo Enzyme
Enhe Bio
Strateos
Asimov
Lattice Automation
HighRes Biosolutions
Integrated DNA Technologies (IDT)
Tidetron Bio
Synthetic Biology Automation Platform Segment by Type
small Production
Mass Production
Synthetic Biology Automation Platform Segment by Application
Chemicals
Pharmaceuticals
Food
Others
Synthetic Biology Automation Platform Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Synthetic Biology Automation Platform status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Synthetic Biology Automation Platform key companies, revenue, market share, and recent developments.
3. To split the Synthetic Biology Automation Platform breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Synthetic Biology Automation Platform market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Synthetic Biology Automation Platform significant trends, drivers, influence factors in global and regions.
6. To analyze Synthetic Biology Automation Platform competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Synthetic Biology Automation Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Synthetic Biology Automation Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Synthetic Biology Automation Platform.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Synthetic Biology Automation Platform industry.
Chapter 3: Detailed analysis of Synthetic Biology Automation Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Synthetic Biology Automation Platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Synthetic Biology Automation Platform in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- small Production
- Mass Production
Applications
- Chemicals
- Pharmaceuticals
- Food
- Others
Companies covered
- Ginkgo Bioworks
- Amyris
- Codexis
- Ningbo Enzyme
- Enhe Bio
- Strateos
- Asimov
- Lattice Automation
- HighRes Biosolutions
- Integrated DNA Technologies (IDT)
- Tidetron Bio
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Synthetic Biology Automation Platform Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Synthetic Biology Automation Platform Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Synthetic Biology Automation Platform Market Dynamics
- 2.1 Synthetic Biology Automation Platform Industry Trends
- 2.2 Synthetic Biology Automation Platform Industry Drivers
- 2.3 Synthetic Biology Automation Platform Industry Opportunities and Challenges
- 2.4 Synthetic Biology Automation Platform Industry Restraints
3 Synthetic Biology Automation Platform Market by Company
- 3.1 Global Synthetic Biology Automation Platform Company Revenue Ranking in 2025
- 3.2 Global Synthetic Biology Automation Platform Revenue by Company (2021-2026)
- 3.3 Global Synthetic Biology Automation Platform Company Ranking (2024-2026)
- 3.4 Global Synthetic Biology Automation Platform Company Manufacturing Base and Headquarters
- 3.5 Global Synthetic Biology Automation Platform Company Product Type and Application
- 3.6 Global Synthetic Biology Automation Platform Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Synthetic Biology Automation Platform Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Synthetic Biology Automation Platform Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Synthetic Biology Automation Platform Market by Type
- 4.1 Synthetic Biology Automation Platform Type Introduction
- 4.1.1 small Production
- 4.1.2 Mass Production
- 4.2 Global Synthetic Biology Automation Platform Sales Value by Type
- 4.2.1 Global Synthetic Biology Automation Platform Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Synthetic Biology Automation Platform Sales Value by Type (2021-2032)
- 4.2.3 Global Synthetic Biology Automation Platform Sales Value Share by Type (2021-2032)
5 Synthetic Biology Automation Platform Market by Application
- 5.1 Synthetic Biology Automation Platform Application Introduction
- 5.1.1 Chemicals
- 5.1.2 Pharmaceuticals
- 5.1.3 Food
- 5.1.4 Others
- 5.2 Global Synthetic Biology Automation Platform Sales Value by Application
- 5.2.1 Global Synthetic Biology Automation Platform Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Synthetic Biology Automation Platform Sales Value by Application (2021-2032)
- 5.2.3 Global Synthetic Biology Automation Platform Sales Value Share by Application (2021-2032)
6 Synthetic Biology Automation Platform Regional Value Analysis
- 6.1 Global Synthetic Biology Automation Platform Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Synthetic Biology Automation Platform Sales Value by Region (2021-2032)
- 6.2.1 Global Synthetic Biology Automation Platform Sales Value by Region: 2021-2026
- 6.2.2 Global Synthetic Biology Automation Platform Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Synthetic Biology Automation Platform Sales Value (2021-2032)
- 6.3.2 North America Synthetic Biology Automation Platform Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Synthetic Biology Automation Platform Sales Value (2021-2032)
- 6.4.2 Europe Synthetic Biology Automation Platform Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Synthetic Biology Automation Platform Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Synthetic Biology Automation Platform Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Synthetic Biology Automation Platform Sales Value (2021-2032)
- 6.6.2 South America Synthetic Biology Automation Platform Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Synthetic Biology Automation Platform Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Synthetic Biology Automation Platform Sales Value Share by Country, 2025 VS 2032
7 Synthetic Biology Automation Platform Country-level Value Analysis
- 7.1 Global Synthetic Biology Automation Platform Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Synthetic Biology Automation Platform Sales Value by Country (2021-2032)
- 7.2.1 Global Synthetic Biology Automation Platform Sales Value by Country (2021-2026)
- 7.2.2 Global Synthetic Biology Automation Platform Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
- 7.7.2 France Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
- 7.14.2 China Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
- 7.17.2 India Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Synthetic Biology Automation Platform Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Synthetic Biology Automation Platform Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Synthetic Biology Automation Platform Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Ginkgo Bioworks
- 8.1.1 Ginkgo Bioworks Company Information
- 8.1.2 Ginkgo Bioworks Business Overview
- 8.1.3 Ginkgo Bioworks Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
- 8.1.4 Ginkgo Bioworks Synthetic Biology Automation Platform Product Portfolio
- 8.1.5 Ginkgo Bioworks Recent Developments
- 8.2 Amyris
- 8.2.1 Amyris Company Information
- 8.2.2 Amyris Business Overview
- 8.2.3 Amyris Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
- 8.2.4 Amyris Synthetic Biology Automation Platform Product Portfolio
- 8.2.5 Amyris Recent Developments
- 8.3 Codexis
- 8.3.1 Codexis Company Information
- 8.3.2 Codexis Business Overview
- 8.3.3 Codexis Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
- 8.3.4 Codexis Synthetic Biology Automation Platform Product Portfolio
- 8.3.5 Codexis Recent Developments
- 8.4 Ningbo Enzyme
- 8.4.1 Ningbo Enzyme Company Information
- 8.4.2 Ningbo Enzyme Business Overview
- 8.4.3 Ningbo Enzyme Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
- 8.4.4 Ningbo Enzyme Synthetic Biology Automation Platform Product Portfolio
- 8.4.5 Ningbo Enzyme Recent Developments
- 8.5 Enhe Bio
- 8.5.1 Enhe Bio Company Information
- 8.5.2 Enhe Bio Business Overview
- 8.5.3 Enhe Bio Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
- 8.5.4 Enhe Bio Synthetic Biology Automation Platform Product Portfolio
- 8.5.5 Enhe Bio Recent Developments
- 8.6 Strateos
- 8.6.1 Strateos Company Information
- 8.6.2 Strateos Business Overview
- 8.6.3 Strateos Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
- 8.6.4 Strateos Synthetic Biology Automation Platform Product Portfolio
- 8.6.5 Strateos Recent Developments
- 8.7 Asimov
- 8.7.1 Asimov Company Information
- 8.7.2 Asimov Business Overview
- 8.7.3 Asimov Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
- 8.7.4 Asimov Synthetic Biology Automation Platform Product Portfolio
- 8.7.5 Asimov Recent Developments
- 8.8 Lattice Automation
- 8.8.1 Lattice Automation Company Information
- 8.8.2 Lattice Automation Business Overview
- 8.8.3 Lattice Automation Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
- 8.8.4 Lattice Automation Synthetic Biology Automation Platform Product Portfolio
- 8.8.5 Lattice Automation Recent Developments
- 8.9 HighRes Biosolutions
- 8.9.1 HighRes Biosolutions Company Information
- 8.9.2 HighRes Biosolutions Business Overview
- 8.9.3 HighRes Biosolutions Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
- 8.9.4 HighRes Biosolutions Synthetic Biology Automation Platform Product Portfolio
- 8.9.5 HighRes Biosolutions Recent Developments
- 8.10 Integrated DNA Technologies (IDT)
- 8.10.1 Integrated DNA Technologies (IDT) Company Information
- 8.10.2 Integrated DNA Technologies (IDT) Business Overview
- 8.10.3 Integrated DNA Technologies (IDT) Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
- 8.10.4 Integrated DNA Technologies (IDT) Synthetic Biology Automation Platform Product Portfolio
- 8.10.5 Integrated DNA Technologies (IDT) Recent Developments
- 8.11 Tidetron Bio
- 8.11.1 Tidetron Bio Company Information
- 8.11.2 Tidetron Bio Business Overview
- 8.11.3 Tidetron Bio Synthetic Biology Automation Platform Revenue and Gross Margin (2021-2026)
- 8.11.4 Tidetron Bio Synthetic Biology Automation Platform Product Portfolio
- 8.11.5 Tidetron Bio Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst